NO20063944L - Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister - Google Patents

Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister

Info

Publication number: NO20063944L
Authority: NO; Norway
Prior art keywords: piperidinylcarbonyl; pyrrolidines; melanocortin agonists; melanocortin; agonists
Prior art date: 2004-02-04

Application number

NO20063944A

Other languages

English (en)

Norwegian (no)

Inventor

David Hepworth

Andrew Calabrese

David Sebastien Fradet

Mark Landsdell

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-04

Filing date

2006-09-04

Publication date

2006-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34864830&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20063944(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-06-03 Priority claimed from GB0412417A external-priority patent/GB0412417D0/en

2004-11-19 Priority claimed from GB0425530A external-priority patent/GB0425530D0/en

2006-09-04 Application filed by Pfizer filed Critical Pfizer

2006-10-31 Publication of NO20063944L publication Critical patent/NO20063944L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Pregnancy & Childbirth (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Child & Adolescent Psychology (AREA)
Cardiology (AREA)
Anesthesiology (AREA)
Emergency Medicine (AREA)

NO20063944A 2004-02-04 2006-09-04 Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister NO20063944L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB0402492.3A GB0402492D0 (en)	2004-02-04	2004-02-04	Pharmaceutically active compounds
GB0412417A GB0412417D0 (en)	2004-06-03	2004-06-03	Pharmaceutically active compounds
GB0425530A GB0425530D0 (en)	2004-11-19	2004-11-19	Pharmaceutically active compounds
PCT/IB2005/000208 WO2005077935A1 (fr)	2004-02-04	2005-01-26	Piperidinylcarbonyl-pyrrolidines et leur utilisation en tant qu'agonistes de la melanocortine

Publications (1)

Publication Number	Publication Date
NO20063944L true NO20063944L (no)	2006-10-31

Family

ID=34864830

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20063944A NO20063944L (no)	2004-02-04	2006-09-04	Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister

Country Status (25)

Country	Link
EP (1)	EP1716135B1 (fr)
JP (1)	JP4031814B2 (fr)
KR (1)	KR100830763B1 (fr)
CN (1)	CN1930146A (fr)
AP (1)	AP2006003699A0 (fr)
AR (1)	AR048232A1 (fr)
AT (1)	ATE511507T1 (fr)
AU (1)	AU2005213538A1 (fr)
BR (1)	BRPI0507435A (fr)
CA (1)	CA2555800C (fr)
CR (1)	CR8545A (fr)
EA (1)	EA011159B1 (fr)
EC (1)	ECSP066751A (fr)
GB (1)	GB0402492D0 (fr)
GE (1)	GEP20084361B (fr)
IL (1)	IL177004A0 (fr)
MA (1)	MA28348A1 (fr)
NL (1)	NL1028193C2 (fr)
NO (1)	NO20063944L (fr)
PA (1)	PA8623101A1 (fr)
PE (1)	PE20050772A1 (fr)
TW (1)	TWI300066B (fr)
UY (1)	UY28737A1 (fr)
WO (1)	WO2005077935A1 (fr)
ZA (1)	ZA200606236B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1912968A1 (fr) *	2005-08-04	2008-04-23	Pfizer Limited	Composes piperidinoyl-pyrrolidine et piperidinoyl-piperidine
AU2006297443B2 (en) *	2005-09-29	2010-08-12	Merck Sharp & Dohme Corp.	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
AU2006304305B2 (en) *	2005-10-18	2010-04-01	Merck Sharp & Dohme Corp.	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
JP5243274B2 (ja) *	2006-02-23	2013-07-24	ファイザー・リミテッド	４型メラノコルチン受容体アゴニストのピペリジノイルピロリジン
EA200801738A1 (ru) *	2006-02-23	2008-12-30	Пфайзер Лимитед	Пиперидиноилпирролидиновые агонисты меланокортинового рецептора 4 типа
ES2406685T3 (es)	2007-08-07	2013-06-07	Takeda Pharmaceutical Company Limited	Derivados de pirrolidin-2-ona como moduladores de los receptores de andrógenos
UA99555C2 (en)	2008-11-12	2012-08-27	Элджи Лайф Саенсез Лтд.	Melanocortin receptor agonists
US8476227B2 (en)	2010-01-22	2013-07-02	Ethicon Endo-Surgery, Inc.	Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9044606B2 (en)	2010-01-22	2015-06-02	Ethicon Endo-Surgery, Inc.	Methods and devices for activating brown adipose tissue using electrical energy
SG11201609864UA (en)	2014-05-29	2016-12-29	Mitsubishi Tanabe Pharma Corp	Novel pyrrolidine compound and application as melanocortin receptor agonist
US10080884B2 (en)	2014-12-29	2018-09-25	Ethicon Llc	Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en)	2014-12-29	2018-10-09	Ethicon Llc	Methods and devices for inhibiting nerves when activating brown adipose tissue
PE20180690A1 (es)	2015-04-27	2018-04-23	Intercept Pharmaceuticals Inc	Composiciones de acido obeticolico y metodos de uso
CA2995188A1 (fr)	2015-08-04	2017-02-09	Astellas Pharma Inc.	Derive de piperazine
CN112694436B (zh) *	2020-12-30	2022-07-08	济南周行医药科技有限公司	一种槟榔碱的合成方法
CN114211258B (zh) *	2021-11-04	2023-09-26	江阴市大久金属科技有限公司	高精密无缝钢管制备工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1383501B1 (fr) *	2001-02-28	2007-04-04	Merck & Co., Inc.	Derives de piperidine acyles utilises comme agonistes du recepteur de la melanocortin-4
CA2439149C (fr) *	2001-02-28	2012-04-24	Merck & Co., Inc.	Derives de piperidine acylatee utilises comme agonistes du recepteur de la melanocortine-4

2004
- 2004-02-04 GB GBGB0402492.3A patent/GB0402492D0/en not_active Ceased
2005
- 2005-01-26 EA EA200601279A patent/EA011159B1/ru not_active IP Right Cessation
- 2005-01-26 CN CNA2005800075736A patent/CN1930146A/zh active Pending
- 2005-01-26 AU AU2005213538A patent/AU2005213538A1/en not_active Abandoned
- 2005-01-26 JP JP2006551945A patent/JP4031814B2/ja not_active Expired - Fee Related
- 2005-01-26 AP AP2006003699A patent/AP2006003699A0/xx unknown
- 2005-01-26 AT AT05702363T patent/ATE511507T1/de not_active IP Right Cessation
- 2005-01-26 WO PCT/IB2005/000208 patent/WO2005077935A1/fr active Application Filing
- 2005-01-26 GE GEAP20059564A patent/GEP20084361B/en unknown
- 2005-01-26 EP EP05702363A patent/EP1716135B1/fr not_active Expired - Lifetime
- 2005-01-26 BR BRPI0507435-5A patent/BRPI0507435A/pt not_active IP Right Cessation
- 2005-01-26 KR KR1020067015811A patent/KR100830763B1/ko not_active IP Right Cessation
- 2005-01-26 CA CA2555800A patent/CA2555800C/fr not_active Expired - Fee Related
- 2005-02-02 PE PE2005000122A patent/PE20050772A1/es not_active Application Discontinuation
- 2005-02-03 UY UY28737A patent/UY28737A1/es not_active Application Discontinuation
- 2005-02-03 AR ARP050100409A patent/AR048232A1/es not_active Application Discontinuation
- 2005-02-03 TW TW094103372A patent/TWI300066B/zh active
- 2005-02-04 PA PA20058623101A patent/PA8623101A1/es unknown
- 2005-02-04 NL NL1028193A patent/NL1028193C2/nl not_active IP Right Cessation
2006
- 2006-07-20 IL IL177004A patent/IL177004A0/en unknown
- 2006-07-27 ZA ZA200606236A patent/ZA200606236B/xx unknown
- 2006-08-03 EC EC2006006751A patent/ECSP066751A/es unknown
- 2006-08-03 CR CR8545A patent/CR8545A/es not_active Application Discontinuation
- 2006-08-04 MA MA29242A patent/MA28348A1/fr unknown
- 2006-09-04 NO NO20063944A patent/NO20063944L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ECSP066751A (es)	2006-11-16
UY28737A1 (es)	2005-09-30
EA011159B1 (ru)	2009-02-27
NL1028193A1 (nl)	2005-08-08
NL1028193C2 (nl)	2006-04-20
JP2007534668A (ja)	2007-11-29
IL177004A0 (en)	2006-12-10
PA8623101A1 (es)	2006-05-16
TWI300066B (en)	2008-08-21
WO2005077935A1 (fr)	2005-08-25
BRPI0507435A (pt)	2007-07-03
CR8545A (es)	2007-09-03
AR048232A1 (es)	2006-04-12
AP2006003699A0 (en)	2006-08-31
MA28348A1 (fr)	2006-12-01
EP1716135A1 (fr)	2006-11-02
CA2555800A1 (fr)	2005-08-25
CN1930146A (zh)	2007-03-14
ZA200606236B (en)	2008-04-30
PE20050772A1 (es)	2005-10-31
GB0402492D0 (en)	2004-03-10
JP4031814B2 (ja)	2008-01-09
GEP20084361B (en)	2008-04-29
EA200601279A1 (ru)	2006-12-29
KR20060127125A (ko)	2006-12-11
ATE511507T1 (de)	2011-06-15
TW200526625A (en)	2005-08-16
KR100830763B1 (ko)	2008-05-19
CA2555800C (fr)	2010-06-15
AU2005213538A1 (en)	2005-08-25
EP1716135B1 (fr)	2011-06-01

Publication	Publication Date	Title
NO20063944L (no)	2006-10-31	Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
NO20081217L (no)	2008-04-15	Nye benzotiazolonderivater
NO20084583L (no)	2008-12-04	Makrosykliske kinase-inhibitorer
NO20090628L (no)	2009-04-21	Pyridizinon derivativater
NO20074275L (no)	2007-09-27	2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
NO20080675L (no)	2008-03-13	P38-Map kinaseinhibitorer og metoder for deres anvendelse
ATE553106T1 (de)	2012-04-15	Heteroarylpyrrolopyridinone als kinaseinhibitoren
NO20065946L (no)	2006-12-20	DPP-IV-inhibitorer
NO20073791L (no)	2007-08-30	Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
BRPI0608886B8 (pt)	2021-05-25	derivados de n-sulfonilpirróis e seus usos
NO20062020L (no)	2006-07-10	1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
NO20062021L (no)	2006-07-07	Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20071242L (no)	2007-05-07	Triazolpyridinylsulfanylderivater som P38-MAP-kinaseinhibitorer
UA94129C2 (ru)	2011-04-11	Соединения для ингибирования митоза
NO20084923L (no)	2008-11-24	N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer
NO20054905L (no)	2006-01-25	2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
NO20070089L (no)	2007-01-05	DPP-IV inhibitorer
NO20061317L (no)	2006-03-23	Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
NO20076145L (no)	2008-01-28	Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
NO20081905L (no)	2008-06-23	Benzotiazolcyklobutylaminderivater og deres anvendelse som histamin-3-reseptorligander
NO20064351L (no)	2006-11-20	Caspaseinhibitorer og anvendelser derav
SE0401762D0 (sv)	2004-07-05	Novel compounds
NO20083390L (no)	2008-10-14	Piperaziner og piperidiner som mGluR5-forsterkere
ATE422198T1 (de)	2009-02-15	Arylsulfonylnaphthalinderivate als 5ht2a- antagonisten
NO20080394L (no)	2008-03-14	N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav

Legal Events

Date	Code	Title	Description
2010-08-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application